Digg It - Business

The 9 Biggest Employment Concerns For A New Doctor

1. Have they had associates bef

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ore? How many? How long did they stay? Why did they leave?

2. Were they forced to leave?

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

Was it voluntary? Was it mutually agreeable? Was there any bad blood?

3. Do they have a

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

estrictive covenant for the physician employees? (A restrictive covenant is simply a prom

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

se from you that if you leave the Group for any reason, then you will not be able to prac

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ice medicine for a specific time within a specific location.)

4. Has the Group ever had

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

o go to Court to litigate a restrictive covenant? Why? This is a touchy question. By rais

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ing it, the Group might construe such a question as a feeler for whether they would ever

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

o after you if you violated your restrictive covenant.

"Why would you raise the issue if

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

you never intend to violate our restriction?" "Just curious, I guess," may not pass muste

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

. Instead, simply tell them that you want to know if there have been any employment iss

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

es that have arisen in the Group that ended up in litigation. This way your question stay

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

under the radar and nobody gets the wrong idea about your question.

5. Is anyone in the

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

Group currently involved in a malpractice case?

6. Was anyone in the Group previously in

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

volved in a case?Was there a settlement or verdict against the group?

7. Do these guys (

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

r girls) testify as experts in malpractice or accident cases?

8. Have any disputes with

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

artners ever resulted in litigation?

9. Has your Group ever dissolved and re-formed with

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

new partners?

The answers to these questions will help you analyze whether this is the r

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ght medical group for you to join. Remember, the more information you have before you sig

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

, the better off you'll be during your negotiations and after you sign on the dotted line

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Digg It - The Top Nine Things A Doctor Needs To Know When Negotiating His Employment Contract

Related Articles: